BACKGROUND: MicroRNA-1290 (miR-1290) has been reported to be involved in many diseases and play a key role during the development process. However, the role of miR-1290 in atherosclerosis (AS) is still unclear. METHODS AND RESULTS: The current study showed that the expressions of miR-1290 were high in serum of patients with hyperlipidemia. The functional role of miR-1290 were then investigated in human umbilical vein endothelial cells (HUVECs). Here, we found that miR-1290 expressions were notably enhanced in HUVECs mediated by IL-8. miR-1290 inhibitor repressed monocytic THP-1 cells adhesion to HUVECs by regulating ICAM-1 and VCAM-1, inhibited proliferation through regulating cyclinD1 and PCNA, and inhibited inflammatory response by regulating IL-1β. Mechanistically, we verified that miR-1290 mimic was able to directly target the 3'-UTR of GSK-3β mRNA using luciferase reporter assay. Knockdown of GSK-3β (si-GSK-3β) promoted HUVECs adhesion and the expression of IL-1β, and partially restore the depression effect of miR-1290 inhibitor on HUVECs adhesion and inflammation. In contrast, si-GSK-3β inhibited the proliferation of HUVECs and the expression of cyclinD1 and PCNA. CONCLUSIONS: In summary, our study revealed that miR-1290 promotes IL-8-mediated the adhesion of HUVECs by targeting GSK-3β. However, GSK-3β is not the target protein for miR-1290 to regulate the proliferation of HUVECs. Our findings may provide potential target in atherosclerosis treatment.
Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340(2):115–126
[DOI: 10.1056/NEJM199901143400207]
Ramji DP, Davies TS (2015) Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev 26(6):673–685
[DOI: 10.1016/j.cytogfr.2015.04.003]
DeGraba TJ (2003) The role of inflammation in atherosclerosis. Adv Neurol 92:29–42
[PMID: 12760164]
Chistiakov DA et al (2018) Potential of anti-inflammatory agents for treatment of atherosclerosis. Exp Mol Pathol 104(2):114–124
[DOI: 10.1016/j.yexmp.2018.01.008]
Gerszten RE et al (1999) MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398(6729):718–723
[DOI: 10.1038/19546]
Yue TL et al (1994) Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 75(1):1–7
[DOI: 10.1161/01.RES.75.1.1]
Qin Y et al (2013) Recombinant human CXCL8(3–72)K11R/G31P regulates smooth muscle cell proliferation and migration through blockage of interleukin-8 receptor. IUBMB Life 65(1):67–75
[DOI: 10.1002/iub.1107]
Stark A et al (2005) Animal microRNAs confer robustnessto geneexpression andhave a significant impact on 3’UTR evolution. Cell 123(6):1133–1146
[DOI: 10.1016/j.cell.2005.11.023]
Novak J et al (2015) Mechanistic role of microRNAs in coupling lipid metabolism and atherosclerosis. Adv Exp Med Biol 887:79–100
[DOI: 10.1007/978-3-319-22380-3_5]
Feinberg MW, Moore KJ (2016) MicroRNA regulation of atherosclerosis. Circ Res 118(4):703–720
[DOI: 10.1161/CIRCRESAHA.115.306300]
Santulli G (2015) MicroRNAs distinctively regulate vascular smooth muscle and endothelial cells: functional implications in angiogenesis, atherosclerosis, and in-stent restenosis. Adv Exp Med Biol 887:53–77
[DOI: 10.1007/978-3-319-22380-3_4]
Giral H, Kratzer A, Landmesser U (2016) MicroRNAs in lipid metabolism and atherosclerosis. Best Pract Res Clin Endocrinol Metab 30(5):665–676
[DOI: 10.1016/j.beem.2016.11.010]
Wang J et al (2019) MicroRNA-92a promotes vascular smooth muscle cell proliferation and migration through the ROCK/MLCK signalling pathway. J Cell Mol Med 23(5):3696–3710
[DOI: 10.1111/jcmm.14274]
Lin M et al (2016) sMicroRNA-1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells. Gene 582(2):137–142
[DOI: 10.1016/j.gene.2016.02.001]
Yan L et al (2018) MiR-1290 promotes proliferation, migration, and invasion of glioma cells by targeting LHX6. J Cell Physiol 233(10):6621–6629
[DOI: 10.1002/jcp.26381]
Xiao X et al (2018) miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4. Oncotarget 9(15):11977–11988
[DOI: 10.18632/oncotarget.24046]
Yue KY et al (2019) Neurons can upregulate Cav-1 to increase intake of endothelial cells-derived extracellular vesicles that attenuate apoptosis via miR-1290. Cell Death Dis 10(12):869
[DOI: 10.1038/s41419-019-2100-5]
Wang Q et al (2021) Exosomal MiR-1290 promotes angiogenesis of hepatocellular carcinoma via targeting SMEK1. J Oncol 2021:6617700
[PMID: 33564307]
Li M et al (2021) TMEM98, a novel secretory protein, promotes endothelial cell adhesion as well as vascular smooth muscle cell proliferation and migration. Can J Physiol Pharmacol 99(5):536–548
[DOI: 10.1139/cjpp-2020-0280]
Warboys CM et al (2014) Bidirectional cross-regulation between the endothelial nitric oxide synthase and beta-catenin signalling pathways. Cardiovasc Res 104(1):116–126
[DOI: 10.1093/cvr/cvu173]
Lin P et al (2015) Idebenone protects against oxidized low density lipoprotein induced mitochondrial dysfunction in vascular endothelial cells via GSK3beta/beta-catenin signalling pathways. Biochem Biophys Res Commun 465(3):548–555
[DOI: 10.1016/j.bbrc.2015.08.058]
Bedel A et al (2008) E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein. Circ Res 103(7):694–701
[DOI: 10.1161/CIRCRESAHA.107.166405]
Zhang YZ et al (2018) Vascular peroxide 1 promotes ox-LDL-induced programmed necrosis in endothelial cells through a mechanism involving beta-catenin signaling. Atherosclerosis 274:128–138
[DOI: 10.1016/j.atherosclerosis.2018.04.031]
Wei J et al (2020) Serum miR-1290 and miR-1246 as potential diagnostic biomarkers of human pancreatic cancer. J Cancer 11(6):1325–1333
[DOI: 10.7150/jca.38048]
Liu X et al (2019) Circulating miR-1290 and miR-320d as novel diagnostic biomarkers of human colorectal cancer. J Cancer 10(1):43–50
[DOI: 10.7150/jca.26723]
Zhou W et al (2017) miR-196b/miR-1290 participate in the antitumor effect of resveratrol via regulation of IGFBP3 expression in acute lymphoblastic leukemia. Oncol Rep 37(2):1075–1083
[DOI: 10.3892/or.2016.5321]
Wu K et al (2017) Asiatic acid enhances survival of human AC16 cardiomyocytes under hypoxia by upregulating miR-1290. IUBMB Life 69(9):660–667
[DOI: 10.1002/iub.1648]
Libby P (2012) Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32(9):2045–2051
[DOI: 10.1161/ATVBAHA.108.179705]
Wu G et al (2020) Molecularly engineered macrophage-derived exosomes with inflammation tropism and intrinsic heme biosynthesis for atherosclerosis treatment. Angew Chem Int Ed Engl 59(10):4068–4074
[DOI: 10.1002/anie.201913700]
Cybulsky MI, Gimbrone MA Jr (1991) Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251(4995):788–791
[DOI: 10.1126/science.1990440]
Mestas J, Ley K (2008) Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 18(6):228–232
[DOI: 10.1016/j.tcm.2008.11.004]
Apostolakis S et al (2009) Interleukin 8 and cardiovascular disease. Cardiovasc Res 84(3):353–360
[DOI: 10.1093/cvr/cvp241]
Li Q et al (2018) Xeroderma Pigmentosum Group D (XPD) inhibits the proliferation cycle of vascular smooth muscle cell (VSMC) by activating glycogen synthase kinase 3beta (GSK3beta). Med Sci Monit 24:5951–5959
[DOI: 10.12659/MSM.909614]
Huang X, et al (2016) Asiatic acid attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3beta/HIF-1alpha signaling in rat H9c2 cardiomyocytes. Molecules 21(9).